BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20337593)

  • 1. SENP1 participates in the dynamic regulation of Elk-1 SUMOylation.
    Witty J; Aguilar-Martinez E; Sharrocks AD
    Biochem J; 2010 May; 428(2):247-54. PubMed ID: 20337593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentrin/SUMO specific proteases as novel tissue-selective modulators of vitamin D receptor-mediated signaling.
    Lee WP; Jena S; Doherty D; Ventakesh J; Schimdt J; Furmick J; Widener T; Lemau J; Jurutka PW; Thompson PD
    PLoS One; 2014; 9(2):e89506. PubMed ID: 24586832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SENP1 and SENP2 affect spatial and temporal control of sumoylation in mitosis.
    Cubeñas-Potts C; Goeres JD; Matunis MJ
    Mol Biol Cell; 2013 Nov; 24(22):3483-95. PubMed ID: 24048451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO Signaling by Hypoxic Inactivation of SUMO-Specific Isopeptidases.
    Kunz K; Wagner K; Mendler L; Hölper S; Dehne N; Müller S
    Cell Rep; 2016 Sep; 16(11):3075-3086. PubMed ID: 27626674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases.
    Cheng J; Perkins ND; Yeh ET
    J Biol Chem; 2005 Apr; 280(15):14492-8. PubMed ID: 15701643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets.
    Hajmrle C; Ferdaoussi M; Plummer G; Spigelman AF; Lai K; Manning Fox JE; MacDonald PE
    Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E664-73. PubMed ID: 25139051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a Dual SENP1 and SENP2 Inhibitor.
    Brand M; Bommeli EB; Rütimann M; Lindenmann U; Riedl R
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo.
    Sharma P; Yamada S; Lualdi M; Dasso M; Kuehn MR
    Cell Rep; 2013 May; 3(5):1640-50. PubMed ID: 23684609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SUMO-specific protease SENP1 deSUMOylates p53 and regulates its activity.
    Chauhan KM; Chen Y; Chen Y; Liu AT; Sun XX; Dai MS
    J Cell Biochem; 2021 Feb; 122(2):189-197. PubMed ID: 32786121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct sites in Nup153 mediate interaction with the SUMO proteases SENP1 and SENP2.
    Chow KH; Elgort S; Dasso M; Ullman KS
    Nucleus; 2012 Jul; 3(4):349-58. PubMed ID: 22688647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELK-1 ubiquitination status and transcriptional activity are modulated independently of F-Box protein FBXO25.
    Quintero-Barceinas RS; Gehringer F; Ducker C; Saxton J; Shaw PE
    J Biol Chem; 2021; 296():100214. PubMed ID: 33428929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
    Mirecka A; Morawiec Z; Wozniak K
    Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression.
    Rodríguez-Castañeda F; Lemma RB; Cuervo I; Bengtsen M; Moen LM; Ledsaak M; Eskeland R; Gabrielsen OS
    J Biol Chem; 2018 Oct; 293(40):15439-15454. PubMed ID: 30082317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO1/sentrin/SMT3 specific peptidase 2 modulates target molecules and its corresponding functions.
    Liu SL; Gao FH
    Biochimie; 2018 Sep; 152():6-13. PubMed ID: 29908207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent small ubiquitin-like modifier (SUMO) modification of Maf1 protein controls RNA polymerase III-dependent transcription repression.
    Rohira AD; Chen CY; Allen JR; Johnson DL
    J Biol Chem; 2013 Jun; 288(26):19288-95. PubMed ID: 23673667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and developmental expression of Xenopus laevis SUMO proteases.
    Wang Y; Mukhopadhyay D; Mathew S; Hasebe T; Heimeier RA; Azuma Y; Kolli N; Shi YB; Wilkinson KD; Dasso M
    PLoS One; 2009 Dec; 4(12):e8462. PubMed ID: 20041154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncovalent structure of SENP1 in complex with SUMO2.
    Ambaye ND
    Acta Crystallogr F Struct Biol Commun; 2019 May; 75(Pt 5):332-339. PubMed ID: 31045562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the activity and substrate specificity of the human SENP family of SUMO proteases.
    Mendes AV; Grou CP; Azevedo JE; Pinto MP
    Biochim Biophys Acta; 2016 Jan; 1863(1):139-47. PubMed ID: 26522917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs.
    Mikolajczyk J; Drag M; Békés M; Cao JT; Ronai Z; Salvesen GS
    J Biol Chem; 2007 Sep; 282(36):26217-24. PubMed ID: 17591783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergence of the SUMO and MAPK pathways on the ETS-domain transcription factor Elk-1.
    Yang SH; Sharrocks AD
    Biochem Soc Symp; 2006; (73):121-9. PubMed ID: 16626293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.